RECENT NEWS

Dudley’s laboratory implements the WinPath Enterprise laboratory information system and the latest version of ICE order communications and results reporting in a ‘big bang’ deployment

Aptamer Group the developer of novel Optimer binders to enable innovation in the life sciences industry, has recently opened its new facilities in York Science Park, UK, that will enable it to meet the increasing demand for Optimer technology.

Winter is always a difficult time for blood stocks. Avoidable transfusion and inappropriate use of O D-negative red blood cells remain a challenge for organisations, particularly considering the recent Amber alert issued by NHS Blood & Transplant.

Join this webinar on Tuesday 6 December 2022 (13:00–14:00 GMT) where SHOT Working Expert Group members and representatives from the four UK Blood Services will provide an overview of Patient Blood Management (PBM) activities and share key learning points.

Digital technologies will play a vital role in ensuring the NHS workforce can cope with future demands on the system, according to a new report by Health Education England.

BioPharma Dynamics is expanding its product portfolio for the cell and gene therapy market to offer a range of chemically defined T-cell media, DMSO-free cryopreservation solutions, and recombinant growth factors.

The Native Antigen Company (part of LGC Clinical Diagnostics) has made two key appointments to its management team. Richard White has joined the company as Business Development Manager, and Pardeep Sharda as Senior Product Manager.

US health body the National Institutes of Health (NIH) has launched a new website to make it easier to report a positive or negative COVID-19 test result.

Molecular diagnostics firm Sense Biodetection has announced a new partnership with R-Biopharm. for the non-exclusive distribution in the Netherlands, Belgium, and Luxembourg of Sense’s Veros instrument-free, point-of-care molecular testing platform.

QIAGEN has launched a monkeypox (now renamed mpox by WHO) test for its NeuMoDx automated PCR platform to strengthen surveillance and research into the current outbreak.

Aquyre Biosciences has recognised Lung Cancer Awareness Month by reaching a milestone of over 400 lung biopsy procedures completed using the CelTivity microscopy system.

Fujifilm Irvine Scientific is to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, USA, which will triple the company’s current capacity for liquid cell culture media production.

PerkinElmer has launched ready-to-use adeno-associated virus vectors (AAV) detection kits to support researchers working on gene therapies for a variety of serious diseases.

QuantuMDx and its exclusive UK distributor Menarini are launching the new Q-POC rapid, point-of-care PCR testing device for SARS-CoV-2.

PCR Biosystems has launched a new family of qPCR reagents mixes: Clara Probe Mix, Clara Probe 1-Step Mix and Clara HRM Mix. The cutting-edge Clara family of mixes rely on a novel composition to push the boundaries of performance to meet the challenges of today’s laboratories.

Proscia, a provider of digital and computational pathology solutions, has announced new research on improving the generalisation of an artificial intelligence (AI) classification model with contrastive self-supervised learning.

The Lab Innovations show returned to the NEC, Birmingham, earlier this month to drive sustainability and innovation in laboratories and celebrate its tenth anniversary.

Enalees, a company specialising in the design, development, production and marketing of state-of-the-art rapid molecular diagnostic tests, such as LAMP PCR (Loop-mediated isothermal AMPlification Polymerase Chain Reaction), for the veterinary profession, has announced the establishment of its first European subsidiary in North Yorkshire, UK.

Torrey Pines Scientific has launched the new EchoTherm RHB20 series of remotely controlled heating stations for robotic systems, fume hoods and controlled environmental chambers.

Bio-Rad Laboratories has announced the launch of the Pioneer Antibody Discovery Platform, a new antibody discovery service specifically designed to develop best-in-class biologic candidates.

NIPACS+ will support the creation of regional networks of care and will help the region to transform diagnostic services, as healthcare professionals benefit from a single point of access to medical images.